Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
J Med Microbiol ; 67(10): 1426-1456, 2018 Oct.
Article in English | MEDLINE | ID: mdl-30222536

ABSTRACT

Maternal pertussis vaccination has been introduced in several countries to protect infants from birth until routine infant vaccination takes place. This review assesses existing evidence on the effectiveness and safety of immunization in pregnancy. The search was finalized in April 2017 and was based on searches using several databases. The selection criteria included any experimental or observational study reporting on the immunogenicity, effectiveness or safety of vaccination with a pertussis-containing vaccine in pregnant women and their infants. Following de-duplication and exclusions, we identified 8395 studies, which were reduced to 46 for inclusion. The overall risk of bias was low, with the exception of some early studies and pharmacovigilance safety data. The evidence demonstrates efficient transplacental transfer of maternal antibodies in infants whose mothers were vaccinated with Tdap or Tdap/IPV in pregnancy, with good evidence that this protects against disease in young infants. Safety studies covering more than 150 000 women vaccinated mostly in the late second or third trimesters are generally consistent and provide reassurance of no significant increased risk of recognized maternal conditions or of adverse events (including congenital anomalies) in infants born to vaccinated women. The clinical significance of reduced seroconversion to pertussis following routine immunization is not yet clear, but no increased risk of pertussis in infants whose mothers were vaccinated in pregnancy was found following primary immunizations in North American and English studies. Most post-booster studies suggest that any blunting effect is short-lived and that longer-term protection in infants from active immunization is not compromised.


Subject(s)
Bordetella pertussis/immunology , Infant, Newborn, Diseases/prevention & control , Pertussis Vaccine/administration & dosage , Whooping Cough/prevention & control , Bordetella pertussis/genetics , Bordetella pertussis/physiology , Female , Humans , Infant, Newborn , Infant, Newborn, Diseases/microbiology , Male , Maternal-Fetal Exchange , Pertussis Vaccine/immunology , Pregnancy , Vaccination , Whooping Cough/embryology
4.
Bull World Health Organ ; 92(12): 868-880D, 2014 Dec 01.
Article in English | MEDLINE | ID: mdl-25552771

ABSTRACT

OBJECTIVE: To assess the effectiveness of internal and international travel restrictions in the rapid containment of influenza. METHODS: We conducted a systematic review according to the requirements of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. Health-care databases and grey literature were searched and screened for records published before May 2014. Data extraction and assessments of risk of bias were undertaken by two researchers independently. Results were synthesized in a narrative form. FINDINGS: The overall risk of bias in the 23 included studies was low to moderate. Internal travel restrictions and international border restrictions delayed the spread of influenza epidemics by one week and two months, respectively. International travel restrictions delayed the spread and peak of epidemics by periods varying between a few days and four months. Travel restrictions reduced the incidence of new cases by less than 3%. Impact was reduced when restrictions were implemented more than six weeks after the notification of epidemics or when the level of transmissibility was high. Travel restrictions would have minimal impact in urban centres with dense populations and travel networks. We found no evidence that travel restrictions would contain influenza within a defined geographical area. CONCLUSION: Extensive travel restrictions may delay the dissemination of influenza but cannot prevent it. The evidence does not support travel restrictions as an isolated intervention for the rapid containment of influenza. Travel restrictions would make an extremely limited contribution to any policy for rapid containment of influenza at source during the first emergence of a pandemic virus.


Subject(s)
Communicable Disease Control/methods , Influenza, Human/epidemiology , Influenza, Human/prevention & control , Pandemics/prevention & control , Travel , Global Health , Humans , Influenza, Human/transmission , Program Evaluation , Public Health Practice , Time Factors
5.
Influenza Other Respir Viruses ; 7 Suppl 2: 93-96, 2013 Sep.
Article in English | MEDLINE | ID: mdl-24034492

ABSTRACT

Healthcare workers (HCWs) are at increased risk of exposure to respiratory pathogens and may transmit infection to vulnerable patients. This study summarises a recent systematic review, which aimed to assess evidence that influenza or pneumococcal vaccination of HCWs provides indirect protection for those patients most at risk of severe or complicated acute respiratory infection. A number of healthcare databases and sources of grey literature were searched using a predefined strategy, and citations screened for eligibility in accordance with specified inclusion criteria. Risk of bias was assessed using validated tools and results summarised qualitatively. Twenty papers were included in the final review, all of which considered influenza vaccination of HCW. As such, planned subanalysis of pneumococcal vaccination was discarded. The majority of primary research studies included (11/14) were conducted in long-term care facilities, but there was marked heterogeneity in terms of the population, intervention/exposure and outcomes considered. Consistency in the direction of effect was observed across several different outcome measures, suggesting that influenza vaccination of HCWs is likely to offer some protection. Further evidence is, however, required from acute care settings.


Subject(s)
Cross Infection/prevention & control , Cross Infection/transmission , Health Personnel , Influenza Vaccines/administration & dosage , Influenza, Human/prevention & control , Influenza, Human/transmission , Vaccination/statistics & numerical data , Humans , Respiratory Distress Syndrome/prevention & control
6.
PLoS One ; 7(8): e41638, 2012.
Article in English | MEDLINE | ID: mdl-22870239

ABSTRACT

INTRODUCTION: The Influenza Clinical Information Network (FLU-CIN) was established to gather detailed clinical and epidemiological information about patients with laboratory confirmed A(H1N1)pdm09 infection in UK hospitals. This report focuses on the clinical course and outcomes of infection in pregnancy. METHODS: A standardised data extraction form was used to obtain detailed clinical information from hospital case notes and electronic records, for patients with PCR-confirmed A(H1N1)pdm09 infection admitted to 13 sentinel hospitals in five clinical 'hubs' and a further 62 non-sentinel hospitals, between 11th May 2009 and 31st January 2010.Outcomes were compared for pregnant and non-pregnant women aged 15-44 years, using univariate and multivariable techniques. RESULTS: Of the 395 women aged 15-44 years, 82 (21%) were pregnant; 73 (89%) in the second or third trimester. Pregnant women were significantly less likely to exhibit severe respiratory distress at initial assessment (OR = 0.49 (95% CI: 0.30-0.82)), require supplemental oxygen on admission (OR = 0.40 (95% CI: 0.20-0.80)), or have underlying co-morbidities (p-trend <0.001). However, they were equally likely to be admitted to high dependency (Level 2) or intensive care (Level 3) and/or to die, after adjustment for potential confounders (adj. OR = 0.93 (95% CI: 0.46-1.92). Of 11 pregnant women needing Level 2/3 care, 10 required mechanical ventilation and three died. CONCLUSIONS: Since the expected prevalence of pregnancy in the source population was 6%, our data suggest that pregnancy greatly increased the likelihood of hospital admission with A(H1N1)pdm09. Pregnant women were less likely than non-pregnant women to have respiratory distress on admission, but severe outcomes were equally likely in both groups.


Subject(s)
Hospitalization , Influenza A Virus, H1N1 Subtype , Influenza, Human/epidemiology , Influenza, Human/physiopathology , Pandemics , Pregnancy Complications, Infectious/epidemiology , Adolescent , Adult , Case-Control Studies , Female , Humans , Influenza, Human/complications , Influenza, Human/therapy , Pregnancy , Pregnancy Complications, Infectious/therapy , Prevalence , Respiratory Distress Syndrome/epidemiology , Respiratory Distress Syndrome/etiology , Respiratory Distress Syndrome/therapy , Severity of Illness Index , United Kingdom/epidemiology
7.
Emerg Infect Dis ; 18(8): 1225-34, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22840895

ABSTRACT

Health care workers (HCWs) may transmit respiratory infection to patients. We assessed evidence for the effectiveness of vaccinating HCWs to provide indirect protection for patients at risk for severe or complicated disease after acute respiratory infection. We searched electronic health care databases and sources of gray literature by using a predefined strategy. Risk for bias was assessed by using validated tools, and results were synthesized by using a narrative approach. Seventeen of the 12,352 identified citations met the full inclusion criteria, and 3 additional articles were identified from reference or citation tracking. All considered influenza vaccination of HCWs, and most were conducted in long-term residential care settings. Consistency in the direction of effect was observed across several different outcome measures, suggesting a likely protective effect for patients in residential care settings. However, evidence was insufficient for us to confidently extrapolate this to other at-risk patient groups.


Subject(s)
Health Personnel , Infectious Disease Transmission, Professional-to-Patient/prevention & control , Respiratory Tract Infections/prevention & control , Vaccination , Acute Disease , Aged , Humans , Influenza Vaccines/administration & dosage , Influenza, Human/prevention & control , Influenza, Human/transmission , Risk
8.
Alcohol Alcohol ; 45(1): 30-8, 2010.
Article in English | MEDLINE | ID: mdl-19995853

ABSTRACT

AIMS: The aim of this study was to review systematically, research investigating an association between the continuous performance task (CPT) in children and exposure to alcohol in utero, in order to identify any evidence of a specific deficit in performance. METHODS: Seven electronic databases and three websites were searched. Papers were selected in accordance with specific inclusion criteria and scored in terms of the methodological quality using the Newcastle-Ottawa score. Marked methodological heterogeneity limited the validity of any statistical meta-analysis and a descriptive synthesis was performed instead. RESULTS: A total of 14 papers were identified for inclusion. There was no consistent evidence of any association between prenatal alcohol exposure and correct responses, reaction time, commission or omission errors during CPT testing. Apparent trends in the reported results, however, suggest that a potential effect might have been missed. CONCLUSIONS: Identifying a specific profile of CPT performance may assist in the detection and management of attention deficits amongst children with prenatal alcohol exposure. Future research with more consistent measures of exposure and outcome is, however, required before any valid generalizations about CPT performance can be made.


Subject(s)
Ethanol/adverse effects , Prenatal Exposure Delayed Effects/psychology , Psychomotor Performance/drug effects , Adolescent , Attention/drug effects , Child , Child, Preschool , Female , Humans , Infant , Male , Pregnancy
SELECTION OF CITATIONS
SEARCH DETAIL
...